Insertion of a roo element into the 5' regulatory region.
roo insertion in 5' regulatory region.
roo insertion at nucleotide position +4922.
roo insertion into 5' regulatory region.
Insertion of a roo element in the 5' regulatory region.
Insertion of roo element at +4922.
roo insertion in 5' regulatory region.
roo insertion in the 5' cis regulatory region.
roo insertion at nucleotide position -1170.
Insertion of a 9.2 kb roo-element at map position +4.9 relative to the transcription start site of w.
The wsp1 region has been cloned (Zachar and Bingham, 1982) and sequenced (O'Hare, Murphy, Levis and Rubin, 1984); it is located 1.0-1.9 kb upstream from the 5' end of the start of w+ transcription (Zachar and Bingham, 1982; O'Hare, Levis and Rubin, 1983). wsp1 shows sequence homology and behavior analogous to enhancer sequences (Davison, Chapman, Wedeen and Bingham, 1985). The lesions responsible for wsp1, wsp2 and wsp4 have been analyzed by sequencing cloned portions of these alleles; the breakpoints of wsp3 and wsp81d have also been established by molecular methods. wsp1 carries roo; the other alleles are molecular deletions. Sensitivity to the effect of su(wsp) on eye pigmentation is deleted by wsp81d but not by wsp3 (Davison, Chapman, Wedeen and Bingham, 1985). 8.7 kb insertion map site (kb): +4.92; Origin = insertion of wa copia; '-' values to left (telomere) end; '+' values to right (centromere) end. In spite of the variegated pattern of spots in the eye in this mutant, the transcript is like that of w+ in size, structure and amount (Levis et al., 1984; Pirrotta and Brockl, 1984).
Eye pigmentation is reduced in pharate adults.
Testis colour: pigmentation enhanced.
Eye colour: relatively light, non-uniform distribution of eye colour.
Eye colour: yellowish to brown; fine-grained mottling; male darker than female. Eye colour: yellow, in females with z1, and two synapsed copies of wsp1 in trans (or tandemly repeated). Malpighian tubule colour: wild-type. Affects that deposition of the eye pigments, resulting in a variegated phenotype.
wsp1 has abnormal eye color phenotype, enhanceable by zv77h
wsp1 has abnormal eye color phenotype, enhanceable by z1
wsp1, zv77h has abnormal eye color phenotype, enhanceable by Taf91
wsp1, z1 has abnormal eye color phenotype, enhanceable by Taf91
wsp1, zv77h has abnormal eye color phenotype, enhanceable by e(y)21
wsp1, zv77h has abnormal eye color phenotype, enhanceable by e(y)34
wsp1, z1 has abnormal eye color phenotype, enhanceable by e(y)34
wsp1, zop6 has abnormal eye color phenotype, enhanceable by e(y)34
wsp1, zop6R1 has abnormal eye color phenotype, enhanceable by e(y)34
wsp1, z1 has abnormal eye color phenotype, non-enhanceable by e(y)21
wsp1 has abnormal eye color | pharate adult stage phenotype, suppressible by east1/east1
wsp1 has visible | pharate adult stage phenotype, suppressible by east1/east1
wsp1 has abnormal eye color | pharate adult stage phenotype, suppressible by easthop-7/easthop-7
wsp1 has visible | pharate adult stage phenotype, suppressible by easthop-7/easthop-7
wsp1 has abnormal eye color | pharate adult stage phenotype, suppressible by east1/easthop-7
wsp1 has visible | pharate adult stage phenotype, suppressible by east1/easthop-7
wsp1 has abnormal eye color | pharate adult stage phenotype, suppressible by su(w[sp])[+]/east1
wsp1 has visible | pharate adult stage phenotype, suppressible by su(w[sp])[+]/east1
wsp1 has abnormal eye color | pharate adult stage phenotype, suppressible by easthop-7/east[+]
wsp1 has visible | pharate adult stage phenotype, suppressible by easthop-7/east[+]
wsp1 has abnormal eye color | recessive phenotype, suppressible by Rga[+]/Rga03834
wsp1 has abnormal eye color phenotype, suppressible by eastR63
wsp1 has phenotype, enhanceable by Wowunspecified
wsp1 has phenotype, enhanceable by Wowunspecified/Low1
wsp1 has phenotype, enhanceable by Wowunspecified/Ufo1
wsp1 has phenotype, enhanceable by Wowunspecified/MowEMS/Pcf11EMS2
wsp1 has phenotype, enhanceable by Wowunspecified/MowEMS/Low1/Pcf11EMS2
wsp1 has pigment cell phenotype, enhanceable by RpLP001544
wsp1 has pigment cell phenotype, enhanceable by zv77h
wsp1 has pigment cell phenotype, enhanceable by z1
wsp1, zv77h has pigment cell phenotype, enhanceable by Taf91
wsp1, z1 has pigment cell phenotype, enhanceable by Taf91
wsp1, zv77h has pigment cell phenotype, enhanceable by e(y)21
wsp1, zv77h has pigment cell phenotype, enhanceable by e(y)34
wsp1, z1 has pigment cell phenotype, enhanceable by e(y)34
wsp1, zop6 has pigment cell phenotype, enhanceable by e(y)34
wsp1, zop6R1 has pigment cell phenotype, enhanceable by e(y)34
wsp1 has phenotype, enhanceable by Ts(YLt;2Rt)L52+Ts(YLt;2Lt)R15
wsp1 has phenotype, enhanceable by Ts(YSt;2Rt)B4+Ts(YLt;2Lt)H174
wsp1 has phenotype, enhanceable by Ts(YLt;2Rt)B110+Ts(YLt;2Lt)L138
wsp1 has phenotype, enhanceable by Ts(YLt;2Rt)G10+Ts(YLt;2Lt)R155
wsp1 has phenotype, enhanceable by Dp(2;Y)J64
wsp1 has phenotype, enhanceable by Ts(YLt;3Lt)B116+Ts(YLt;3Rt)G48
wsp1 has phenotype, enhanceable by Ts(YSt;3Rt)G73+Ts(YSt;3Lt)R128
wsp1 has phenotype, non-enhanceable by Kr-h105208
wsp1 has phenotype, non-enhanceable by Wowunspecified/Pcf11EMS2
wsp1 has phenotype, non-enhanceable by Wowunspecified/Low1/Pcf11EMS2
wsp1, z1 has pigment cell phenotype, non-enhanceable by e(y)21
wsp1 has phenotype, non-enhanceable by Ts(YLt;2Lt)R14+Ts(YSt;2Rt)L110
wsp1 has phenotype, non-enhanceable by Ts(YSt;2Lt)H149+Ts(YSt;2Rt)R14
wsp1 has phenotype, non-enhanceable by Ts(YSt;2Rt)L107+Ts(YSt;2Lt)P59
wsp1 has phenotype, non-enhanceable by Ts(YLt;3Lt)B141
wsp1 has phenotype, non-enhanceable by Ts(YSt;3Rt)B141+Ts(YSt;3Lt)G122
wsp1 has phenotype, non-enhanceable by Ts(YLt;3Lt)A31+Ts(YLt;3Rt)G122
wsp1 has phenotype, non-enhanceable by Ts(YSt;3Lt)G48+Ts(YSt;3Rt)R36
wsp1 has phenotype, non-enhanceable by Ts(YSt;2Lt)B110+Ts(YSt;2Rt)R15
wsp1 has phenotype, non-enhanceable by Ts(YSt;2Lt)D20+Ts(YSt;2Rt)L138
wsp1 has phenotype, non-enhanceable by Ts(YSt;2Lt)L23+Ts(YSt;2Rt)R155
wsp1 has eye | pharate adult stage phenotype, suppressible by east1/east1
wsp1 has eye | pharate adult stage phenotype, suppressible by easthop-7/easthop-7
wsp1 has eye | pharate adult stage phenotype, suppressible by east1/easthop-7
wsp1 has eye | pharate adult stage phenotype, suppressible by su(w[sp])[+]/east1
wsp1 has eye | pharate adult stage phenotype, suppressible by easthop-7/east[+]
wsp1 has phenotype, suppressible by Wowunspecified/MowEMS
wsp1 has phenotype, suppressible by Wowunspecified/MowEMS/Low1
wsp1 has pigment cell phenotype, suppressible by Rga[+]/Rga03834
wsp1 has pigment cell phenotype, suppressible by eastR63
wsp1 has phenotype, suppressible by Ts(YLt;3Rt)R128
wsp1 has phenotype, non-suppressible by Kr-h105208
wsp1 has phenotype, non-suppressible by Wowunspecified/Pcf11EMS2
wsp1 has phenotype, non-suppressible by Wowunspecified/Low1/Pcf11EMS2
wsp1 has phenotype, non-suppressible by Ts(YSt;2Lt)B110+Ts(YSt;2Rt)R15
wsp1 has phenotype, non-suppressible by Ts(YSt;2Lt)D20+Ts(YSt;2Rt)L138
wsp1 has phenotype, non-suppressible by Ts(YSt;2Lt)L23+Ts(YSt;2Rt)R155
wsp1 has phenotype, non-suppressible by Ts(YLt;2Lt)R14+Ts(YSt;2Rt)L110
wsp1 has phenotype, non-suppressible by Ts(YSt;2Lt)H149+Ts(YSt;2Rt)R14
wsp1 has phenotype, non-suppressible by Ts(YSt;2Rt)L107+Ts(YSt;2Lt)P59
wsp1 has phenotype, non-suppressible by Ts(YLt;3Lt)B141
wsp1 has phenotype, non-suppressible by Ts(YSt;3Rt)B141+Ts(YSt;3Lt)G122
wsp1 has phenotype, non-suppressible by Ts(YLt;3Lt)A31+Ts(YLt;3Rt)G122
wsp1 has phenotype, non-suppressible by Ts(YSt;3Lt)G48+Ts(YSt;3Rt)R36
sgl05007, wsp1 has pigment cell phenotype
Transheterozygotes with su(wsp)R63 have more red eye pigment than wsp1 flies.
No interaction with mutations of Rm62.
wsp1/wunspecified flies have dark, but not wild-type colour eyes.
Complementation synapsis-dependent.
Showell, 1944.
Located proximal to wch and distal to wDZL.
Frequency of reversion of the 8.7kb roo insertion in both somatic tissue and the germline after larval exposure to three different alkylating agents, EMS, ENU and MMS, is analysed. The mutagens used did not induce excision of roo, the revertant phenotypes obtained are due to second site modifiers acting on w expression.
Shows hyper-dosage compensation.